Over the past decade, robotic neurorehabilitation has become one of the most discussed innovations in neurological recovery. Robotic gait trainers, upper-limb rehabilitation systems, exoskeletons, and AI-assisted rehabilitation devices are increasingly being adopted by hospitals and rehabilitation centres worldwide. However, an important question remains: Are robots the future of neurorehabilitation—or are they simply another tool in the rehabilitation toolbox? As clinicians and researchers, we must move beyond marketing claims and focus on scientific evidence, patient selection, and clinical reasoning. What is Robotic Neurorehabilitation? Robotic neurorehabilitation involves the use of electromechanical devices that assist, guide, resist, or augment movement during therapy. These technologies include: • Robotic gait trainers • Wearable exoskeletons • Upper limb robotic rehabilitation devices • End-effector robotic systems • Sensor-based rehabilitation platforms • AI-assiste...
The journey of
glutamate from its isolation to its recognition as a key neurotransmitter in
the brain is a fascinating story that spans several decades of scientific
discovery. Here is an overview of the milestones in the history of glutamate,
highlighting its isolation and eventual identification as a major
neurotransmitter:
1. Isolation of
Glutamate:
o Glutamate, an
amino acid, was first isolated in 1866 by the German chemist Karl Heinrich
Ritthausen from wheat gluten.
o In the early 20th
century, researchers identified glutamate as a component of protein-rich foods
and a building block of proteins in the body.
2. Identification as
a Neurotransmitter:
o In the 1950s and
1960s, researchers began to investigate the role of glutamate in the central
nervous system.
o In 1957, Daniel
McGeer and John McGeer discovered that glutamate is present in high
concentrations in the brain and spinal cord.
o In the 1960s,
researchers such as John Curtis Watkins and Edward Roberts demonstrated that
glutamate acts as an excitatory neurotransmitter in the brain.
o In the 1970s, the
concept of glutamate as a major neurotransmitter in the brain gained widespread
acceptance, particularly in the field of neuroscience.
3. Glutamate
Receptors:
o In the 1980s and
1990s, researchers identified and characterized several types of glutamate
receptors in the brain, including NMDA (N-methyl-D-aspartate), AMPA
(α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), and kainate receptors.
o These receptors
play crucial roles in synaptic transmission, plasticity, and neuronal
communication.
4. Excitatory
Neurotransmission:
oGlutamate is now
recognized as the primary excitatory neurotransmitter in the central nervous
system, responsible for fast synaptic transmission and neuronal signaling.
o It plays a key
role in processes such as learning, memory, and motor function.
5. Neurological
Implications:
o Dysregulation of
glutamate signaling has been implicated in various neurological disorders,
including epilepsy, stroke, Alzheimer's disease, and Parkinson's disease.
o Research
continues to explore the role of glutamate in brain function and its potential
as a target for therapeutic interventions in neurological and psychiatric
conditions.
Overall, the
journey of glutamate from its isolation as an amino acid to its recognition as
a major neurotransmitter in the brain represents a significant advancement in
our understanding of brain function and neurological disorders.
Comments
Post a Comment